Cost and workload implications of routine [18F]FDG PET/CT screening in breast cancer patients scheduled for preoperative systemic therapy: a real-world data analysis
In the context of rising healthcare costs, increasing cancer incidence, and growing pressure on radiology services and workforce shortages, critical evaluation of [ 18 F]FDG PET/CT use in breast cancer patients is warranted. This study assessed the cost and workload implications of routine [ 18 F]FDG PET/CT in patients scheduled for preoperative systemic therapy (PST). We performed a retrospective real-world data analysis of patients scheduled for PST between 2011 and 2020 at our institute, all of whom underwent [ 18 F]FDG PET/CT prior to treatment. Breast cancer-related and non-breast cancer findings, subsequent diagnostic procedures, and final diagnoses were recorded and classified by clinical relevance. Scenario analyses evaluated the impact of de-escalating [ 18 F]FDG PET/CT use in selected patient groups. Among 1,330 patients, [ 18 F]FDG PET/CT resulted in 522 additional investigations and upstaging in 20% of patients. Total costs were €1,94 million and total workload 2,506 h, of which 24% was attributable to upstaged patients. Mean cost and workload per patient increased with clinical stage, while upstaging rates ranged from 6% (stage I) to 35% (stage III). Incidental, non-breast cancer findings were identified in 13% of patients, accounting for 7% of total diagnostic costs and workload. Omitting [ 18 F]FDG PET/CT in stages I-IIA could reduce estimated annual costs and workload by around 60%. Routine [ 18 F]FDG PET/CT in breast cancer patients undergoing PST is associated with substantial costs and workload, largely driven by findings without impact on treatment planning. In stage I-IIA disease, the limited clinical benefit may not justify routine use, supporting a more selective, value-based approach to pre-PST staging.
Authors
- Astrid N. Scholten (ORCID: https://orcid.org/0000-0002-3242-4989)
- A. Marjolein Schrijver (ORCID: https://orcid.org/0000-0002-2260-3983)
- Jetske L B Gunster (ORCID: https://orcid.org/0000-0002-9287-8181)
- Marcel P. M. Stokkel (ORCID: https://orcid.org/0000-0002-8131-5690)
- Josefien P. van Olmen (ORCID: https://orcid.org/0000-0001-6971-2688)
- Astrid Kramer (ORCID: https://orcid.org/0000-0002-2201-5794)
- Frederieke H van Duijnhoven (ORCID: https://orcid.org/0000-0003-3694-4049)
- Valesca P. Retèl (ORCID: https://orcid.org/0000-0002-5624-3234)
- Corrie Marijnen
Institutions
- Leiden University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1186/s12913-026-15888-y
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00